Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

The heterogeneity of an individual patient’s tumor has been linked to treatment resistance, but quantitative biomarkers to rapidly and reproducibly evaluate heterogeneity in a clinical setting are currently lacking. Using established tools available in a CAP-accredited and CLIA-certified clinical la...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res
Main Authors: Scher, Howard I., Graf, Ryon P., Schreiber, Nicole A., McLaughlin, Brigit, Jendrisak, Adam, Wang, Yipeng, Lee, Jerry, Greene, Stephanie, Krupa, Rachel, Lu, David, Bamford, Pascal, Louw, Jessica E., Dugan, Lyndsey, Vargas, Hebert A., Fleisher, Martin, Landers, Mark, Heller, Glenn, Dittamore, Ryan
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666339/
https://ncbi.nlm.nih.gov/pubmed/28819021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-17-1353
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki